Cogent Biosciences, Inc. COGT
NASDAQ · United States · Health Technology
$31.90-0.13 (-0.39%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.52 | -0.55 | +6.3% | $0 | — | -8.7%$42.39→$38.70 |
| Q1 2026 | 2026-05-05 | -0.53 | -0.53 | 0.0% | — | — | -2.3%$36.73→$35.87 |
| Q4 2025 | 2026-02-17 | -0.56 | -0.51 | -9.8% | — | — | +5.0%$36.53→$38.35 |
| Q3 2025 | 2025-11-07 | -0.50 | -0.52 | +3.8% | — | — | +120.5%$14.72→$32.46 |
| Q4 2024 | 2025-02-25 | -0.09 | -0.58 | +84.5% | — | — | — |
| Q4 2023 | 2024-02-26 | -0.63 | -0.59 | -6.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.